Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (37)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kwee, J.
Right arrow Articles by Schoemaker, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwee, J.
Right arrow Articles by Schoemaker, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 7, 1422-1427, July 2003
© 2003 European Society of Human Reproduction and Embryology

Comparison of endocrine tests with respect to their predictive value on the outcome of ovarian hyperstimulation in IVF treatment: results of a prospective randomized study

J. Kwee1,3, M.W. Elting1, R. Schats1, P.D. Bezemer2, C.B. Lambalk1 and J. Schoemaker1

1 Research Institute for Endocrinology, Reproduction and Metabolism, Department of Obstetrics and Gynaecology, Division of Reproductive Endocrinology and Fertility and the IVF Centre and 2 Department of Clinical Epidemiology and Biostatistics Vrije Universiteit Medical Centre, Amsterdam, The Netherlands

3 To whom correspondence should be addressed at: Vrije Universiteit Medical Centre, IVF Centre P.O.Box 7057, 1007 MB Amsterdam, The Netherlands. e-mail: j.kwee{at}vumc.nl

BACKGROUND: This study was designed to compare endocrine tests [clomiphene citrate challenge test (CCT), exogenous FSH ovarian reserve test (EFORT) and basal FSH, basal estradiol (E2) and basal inhibin B as an integral part of all CCT and EFORT], with respect to their ability to estimate the stimulable cohort of follicles in the ovaries (ovarian capacity) and to analyse which test or combination of tests would give the best prediction of ovarian capacity. METHODS: A total of 110 regularly menstruating patients, aged 18–39 years, participated in this prospective study, randomized by a computer-designed 4-block system study into two groups. Fifty-six patients underwent a CCT, and 54 patients underwent an EFORT. In all patients, the test was followed by an IVF treatment. The result of ovarian hyperstimulation during IVF treatment, expressed by the total number of follicles, was used as gold standard. RESULTS: Univariate linear regression analysis showed that the best correlation with the number of follicles after ovarian hyperstimulation (Y) is found by the inhibin B increment (InhB incr.) in the EFORT (Y = 3.957 + 0.081 x InhB incr. (95% CI 0.061–0.101); r = 0.751; P < 0.001). Multiple linear regression analysis showed a significant contributing value of the variables basal FSH, E2 increment of the EFORT and inhibin B increment to the basic model with the variable age. The best prediction of ovarian capacity (Y) was seen when E2 increment and inhibin B increment were used simultaneously in a stepforward multiple regression prediction model [Y = 2.659 + 0.052 x InhB incr. (0.026–0.078) + 0.027 x E2 incr. (95% CI 0.012–0.054); r = 0.796; P < 0.001]. The CCT could not be used in a prediction model. CONCLUSIONS: The EFORT is the endocrine test which gives the best prediction of ovarian capacity.

Key words: basal FSH/basal inhibin B/CCT/EFORT/ovarian capacity


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
F. J. Broekmans, M. R. Soules, and B. C. Fauser
Ovarian Aging: Mechanisms and Clinical Consequences
Endocr. Rev., August 1, 2009; 30(5): 465 - 493.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C.H. de Koning, J. McDonnell, A.P.N. Themmen, F.H. de Jong, R. Homburg, and C.B. Lambalk
The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls
Hum. Reprod., June 1, 2008; 23(6): 1416 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.L. Haadsma, A. Bukman, H. Groen, E.M.A. Roeloffzen, E.R. Groenewoud, M.J. Heineman, and A. Hoek
The number of small antral follicles (2-6 mm) determines the outcome of endocrine ovarian reserve tests in a subfertile population
Hum. Reprod., July 1, 2007; 22(7): 1925 - 1931.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
F.J. Broekmans, J. Kwee, D.J. Hendriks, B.W. Mol, and C.B. Lambalk
A systematic review of tests predicting ovarian reserve and IVF outcome
Hum. Reprod. Update, November 1, 2006; 12(6): 685 - 718.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C.H. de Koning, T. Benjamins, P. Harms, R. Homburg, J.M. van Montfrans, J. Gromoll, M. Simoni, and C.B. Lambalk
The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles
Hum. Reprod., February 1, 2006; 21(2): 443 - 446.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Eldar-Geva, A. Ben-Chetrit, I. M. Spitz, R. Rabinowitz, E. Markowitz, T. Mimoni, M. Gal, E. Zylber-Haran, and E. J. Margalioth
Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome
Hum. Reprod., November 1, 2005; 20(11): 3178 - 3183.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
E. H. Y. Ng, C. C. W. Chan, O. S. Tang, and P. C. Ho
Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment
Hum. Reprod., June 1, 2005; 20(6): 1647 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
ESHRE Capri Workshop Group
Fertility and ageing
Hum. Reprod. Update, May 1, 2005; 11(3): 261 - 276.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
K. Lutchman Singh, M. Davies, and R. Chatterjee
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D.J. Hendriks, F.J.M. Broekmans, L.F.J.M.M. Bancsi, F.H. de Jong, C.W.N. Looman, and E.R. te Velde
Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve
Hum. Reprod., January 1, 2005; 20(1): 163 - 169.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Lass
Assessment of ovarian reserve: Is there still a role for ovarian biopsy in the light of new data?
Hum. Reprod., March 1, 2004; 19(3): 467 - 469.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. I. Sharara and R. T. Scott
Assessment of ovarian reserve. Is there still a role for ovarian biopsy?: First do no harm!
Hum. Reprod., March 1, 2004; 19(3): 470 - 471.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Kwee, R. Schats, J. McDonnell, C.B. Lambalk, and J. Schoemaker
Intercycle variability of ovarian reserve tests: results of a prospective randomized study
Hum. Reprod., March 1, 2004; 19(3): 590 - 595.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.